Radiofrequency thermal ablation of breast tumors combined with intralesional administration of IL-7 and IL-15 augments anti-tumor immune responses and inhibits tumor development and metastasis

Mehran Habibi, MacIej Kmieciak, Laura Graham, Johanna K. Morales, Harry D. Bear, Masoud H. Manjili

Research output: Contribution to journalArticle

Abstract

Tumor development or recurrence is always a matter of concern following radiofrequency thermal ablation (RFA) of tumors. To determine whether combining RFA with immunologically active cytokines might induce tumor-specific immune responses against mammary carcinoma and inhibit tumor development or metastasis, we evaluated intralesional injection of IL-7 and IL-15 in RFA-treated murine tumors. We used two different breast carcinoma models: neu-overexpressing mouse mammary carcinoma (MMC) in FVBN202 transgenic mouse and 4T1 tumors in Balb/c mouse. MMC tend to relapse even in the presence of neu-specific immune responses, and 4T1 is a weakly immunogenic, aggressive and highly metastatic transplantable tumor. In vivo growth of both of these tumors is also associated with increased numbers of CD11b+Gr1+ myeloid-derived suppressor cells (MDSC). We showed for the first time that unlike RFA alone, RFA combined with the administration of intralesional IL-7 and IL-15 (after RFA), induced immune responses to tumors, inhibited tumor development and lung metastasis, and reduced MDSC.

Original languageEnglish (US)
Pages (from-to)423-431
Number of pages9
JournalBreast Cancer Research and Treatment
Volume114
Issue number3
DOIs
StatePublished - Apr 2009
Externally publishedYes

Fingerprint

Interleukin-15
Interleukin-7
Hot Temperature
Breast Neoplasms
Neoplasm Metastasis
Neoplasms
Intralesional Injections
Recurrence
Transgenic Mice
Cytokines

Keywords

  • Breast cancer
  • Immunotherapy
  • Interleukin 15 (IL-15)
  • Interleukin-7 (IL-7)
  • Myeloid-derived suppressor cells (MDSC)
  • Radiofrequency thermal ablation (RFA)

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Radiofrequency thermal ablation of breast tumors combined with intralesional administration of IL-7 and IL-15 augments anti-tumor immune responses and inhibits tumor development and metastasis. / Habibi, Mehran; Kmieciak, MacIej; Graham, Laura; Morales, Johanna K.; Bear, Harry D.; Manjili, Masoud H.

In: Breast Cancer Research and Treatment, Vol. 114, No. 3, 04.2009, p. 423-431.

Research output: Contribution to journalArticle

@article{ee8e5f2df5bf4089bb2e6a4ddfd62608,
title = "Radiofrequency thermal ablation of breast tumors combined with intralesional administration of IL-7 and IL-15 augments anti-tumor immune responses and inhibits tumor development and metastasis",
abstract = "Tumor development or recurrence is always a matter of concern following radiofrequency thermal ablation (RFA) of tumors. To determine whether combining RFA with immunologically active cytokines might induce tumor-specific immune responses against mammary carcinoma and inhibit tumor development or metastasis, we evaluated intralesional injection of IL-7 and IL-15 in RFA-treated murine tumors. We used two different breast carcinoma models: neu-overexpressing mouse mammary carcinoma (MMC) in FVBN202 transgenic mouse and 4T1 tumors in Balb/c mouse. MMC tend to relapse even in the presence of neu-specific immune responses, and 4T1 is a weakly immunogenic, aggressive and highly metastatic transplantable tumor. In vivo growth of both of these tumors is also associated with increased numbers of CD11b+Gr1+ myeloid-derived suppressor cells (MDSC). We showed for the first time that unlike RFA alone, RFA combined with the administration of intralesional IL-7 and IL-15 (after RFA), induced immune responses to tumors, inhibited tumor development and lung metastasis, and reduced MDSC.",
keywords = "Breast cancer, Immunotherapy, Interleukin 15 (IL-15), Interleukin-7 (IL-7), Myeloid-derived suppressor cells (MDSC), Radiofrequency thermal ablation (RFA)",
author = "Mehran Habibi and MacIej Kmieciak and Laura Graham and Morales, {Johanna K.} and Bear, {Harry D.} and Manjili, {Masoud H.}",
year = "2009",
month = "4",
doi = "10.1007/s10549-008-0024-3",
language = "English (US)",
volume = "114",
pages = "423--431",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - Radiofrequency thermal ablation of breast tumors combined with intralesional administration of IL-7 and IL-15 augments anti-tumor immune responses and inhibits tumor development and metastasis

AU - Habibi, Mehran

AU - Kmieciak, MacIej

AU - Graham, Laura

AU - Morales, Johanna K.

AU - Bear, Harry D.

AU - Manjili, Masoud H.

PY - 2009/4

Y1 - 2009/4

N2 - Tumor development or recurrence is always a matter of concern following radiofrequency thermal ablation (RFA) of tumors. To determine whether combining RFA with immunologically active cytokines might induce tumor-specific immune responses against mammary carcinoma and inhibit tumor development or metastasis, we evaluated intralesional injection of IL-7 and IL-15 in RFA-treated murine tumors. We used two different breast carcinoma models: neu-overexpressing mouse mammary carcinoma (MMC) in FVBN202 transgenic mouse and 4T1 tumors in Balb/c mouse. MMC tend to relapse even in the presence of neu-specific immune responses, and 4T1 is a weakly immunogenic, aggressive and highly metastatic transplantable tumor. In vivo growth of both of these tumors is also associated with increased numbers of CD11b+Gr1+ myeloid-derived suppressor cells (MDSC). We showed for the first time that unlike RFA alone, RFA combined with the administration of intralesional IL-7 and IL-15 (after RFA), induced immune responses to tumors, inhibited tumor development and lung metastasis, and reduced MDSC.

AB - Tumor development or recurrence is always a matter of concern following radiofrequency thermal ablation (RFA) of tumors. To determine whether combining RFA with immunologically active cytokines might induce tumor-specific immune responses against mammary carcinoma and inhibit tumor development or metastasis, we evaluated intralesional injection of IL-7 and IL-15 in RFA-treated murine tumors. We used two different breast carcinoma models: neu-overexpressing mouse mammary carcinoma (MMC) in FVBN202 transgenic mouse and 4T1 tumors in Balb/c mouse. MMC tend to relapse even in the presence of neu-specific immune responses, and 4T1 is a weakly immunogenic, aggressive and highly metastatic transplantable tumor. In vivo growth of both of these tumors is also associated with increased numbers of CD11b+Gr1+ myeloid-derived suppressor cells (MDSC). We showed for the first time that unlike RFA alone, RFA combined with the administration of intralesional IL-7 and IL-15 (after RFA), induced immune responses to tumors, inhibited tumor development and lung metastasis, and reduced MDSC.

KW - Breast cancer

KW - Immunotherapy

KW - Interleukin 15 (IL-15)

KW - Interleukin-7 (IL-7)

KW - Myeloid-derived suppressor cells (MDSC)

KW - Radiofrequency thermal ablation (RFA)

UR - http://www.scopus.com/inward/record.url?scp=61449147270&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61449147270&partnerID=8YFLogxK

U2 - 10.1007/s10549-008-0024-3

DO - 10.1007/s10549-008-0024-3

M3 - Article

C2 - 18425677

AN - SCOPUS:61449147270

VL - 114

SP - 423

EP - 431

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 3

ER -